Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274625 · ClinicalTrials.gov registry record · NA
Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery
A NA study of Obesity and Hernia, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 402
- Enrollment target
- 2
- Study locations
NCT00274625: Completed NA study of Obesity and Hernia, sponsored by Cook Group Incorporated.
NCT00274625 is a NA study of Obesity and Hernia that has completed, run by Cook Group Incorporated. The registered enrollment target is 402 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00274625, a NA study of Obesity and Hernia, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective is to compare the effectiveness of the Surgisis Gold Graft to suture closure alone in preventing an incisional hernia after open bariatric surgery.
Primary Outcome
An obvious defect or interruption of the fascia in the area of the incision that was palpable on clinical examination and/or visible by a cross-sectional imaging modality.
Interventions
- PROCEDURE Control
- DEVICE Surgisis Gold Graft
Study Locations (2)
Minnesota
- Mayo Clinic Foundation - Rochester
Virginia
- St. Mary's Medical - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2005-08 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00274625 record still lists
NCT00274625 is an interventional study that assigns participants to a tested intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT00274625 reports a single indexed study location in Minnesota, Virginia.
Frequently Asked Questions
What is clinical trial NCT00274625 about?
NCT00274625 is a clinical study titled "Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery". The primary objective is to compare the effectiveness of the Surgisis Gold Graft to suture closure alone in preventing an incisional hernia after open bariatric surgery.
What is the current status of trial NCT00274625?
This trial is currently completed. It is a NA study. The enrollment target is 402 participants. The study started on 2005-08. Estimated completion is 2012-09.
What conditions does trial NCT00274625 study?
This clinical trial studies the following conditions: Obesity, Hernia.
What interventions are being tested in trial NCT00274625?
The interventions under investigation include: Control (PROCEDURE), Surgisis Gold Graft (DEVICE).
Who is sponsoring clinical trial NCT00274625?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00274625 being conducted?
This trial has 2 study locations across Minnesota, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00274625's enrollment target sits among peer trials
402 169th of 1053 higher than 885 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia